GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ambu AS (OTCPK:AMBFF) » Definitions » Days Sales Outstanding

AMBFF (Ambu AS) Days Sales Outstanding : 49.24 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ambu AS Days Sales Outstanding?

Ambu AS's average Accounts Receivable for the three months ended in Mar. 2025 was $121.5 Mil. Ambu AS's Revenue for the three months ended in Mar. 2025 was $225.2 Mil. Hence, Ambu AS's Days Sales Outstanding for the three months ended in Mar. 2025 was 49.24.

The historical rank and industry rank for Ambu AS's Days Sales Outstanding or its related term are showing as below:

AMBFF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.65   Med: 60.5   Max: 82.41
Current: 49.65

During the past 13 years, Ambu AS's highest Days Sales Outstanding was 82.41. The lowest was 49.65. And the median was 60.50.

AMBFF's Days Sales Outstanding is ranked better than
71.27% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 66.43 vs AMBFF: 49.65

Ambu AS's Days Sales Outstanding increased from Mar. 2024 (46.27) to Mar. 2025 (49.24).


Ambu AS Days Sales Outstanding Historical Data

The historical data trend for Ambu AS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambu AS Days Sales Outstanding Chart

Ambu AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.25 55.50 64.82 55.82 50.15

Ambu AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.27 50.41 49.24 48.82 49.24

Competitive Comparison of Ambu AS's Days Sales Outstanding

For the Medical Devices subindustry, Ambu AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ambu AS's Days Sales Outstanding falls into.


;
;

Ambu AS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ambu AS's Days Sales Outstanding for the fiscal year that ended in Sep. 2024 is calculated as

Days Sales Outstanding (A: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (109.621 + 110.896) / 2 ) / 802.471*365
=110.2585 / 802.471*365
=50.15

Ambu AS's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (115.977 + 127.114) / 2 ) / 225.24*365 / 4
=121.5455 / 225.24*365 / 4
=49.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambu AS  (OTCPK:AMBFF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ambu AS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ambu AS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambu AS Business Description

Address
Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and Rest of the world.

Ambu AS Headlines

From GuruFocus

Q3 2020 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Ambu A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Q4 2023 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2020 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2024 Ambu A/S Earnings Call Transcript

By GuruFocus Research 08-31-2024

Q4 2021 Ambu A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024